Abingdon, United Kingdom

Nina Connelly Ursinyova

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nina Connelly Ursinyova. Retrieved from https://idiyas.com/inventor/nina-connelly-ursinyova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nina Connelly Ursinyova: Innovator in Pharmaceutical Chemistry

Introduction

Nina Connelly Ursinyova is a distinguished inventor based in Abingdon, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. Her work focuses on neurogenic diseases, showcasing her commitment to advancing healthcare through scientific research.

Latest Patents

Nina holds a patent for "Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors." This invention encompasses substituted Pyrazolo-pyrrolo-pyrimidine-dione (PPPD) compounds, which are designed to treat or prevent diseases, especially neurogenic conditions. The patent details methods for preparing these compounds, as well as their pharmaceutical compositions and combinations for effective treatment.

Career Highlights

Throughout her career, Nina has worked with prominent companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. Her experience in these organizations has allowed her to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Nina has collaborated with notable professionals in her field, including Marcus Koppitz and Holger Siebeneicher. These partnerships have further enriched her research and innovation efforts.

Conclusion

Nina Connelly Ursinyova exemplifies the spirit of innovation in pharmaceutical chemistry. Her contributions through patents and collaborations highlight her dedication to improving medical treatments for neurogenic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…